{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T09:49:09Z","timestamp":1768643349299,"version":"3.49.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T00:00:00Z","timestamp":1594252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T00:00:00Z","timestamp":1594252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National Hospital Organization Network Research Fund","award":["H30-NHO-Sensory Organs-03"],"award-info":[{"award-number":["H30-NHO-Sensory Organs-03"]}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"crossref","award":["18ek0109282h0002"],"award-info":[{"award-number":["18ek0109282h0002"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Doc Ophthalmol"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s10633-020-09782-z","type":"journal-article","created":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T16:06:43Z","timestamp":1594310803000},"page":"87-98","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Progress of macular atrophy during 30 months\u2019 follow-up in a patient with spinocerebellar ataxia type1 (SCA1)"],"prefix":"10.1007","volume":"142","author":[{"given":"Ayane","family":"Hirose","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Katagiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaaki","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomokazu","family":"Matsuura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihiro","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaoru","family":"Fujinami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7875-342X","authenticated-orcid":false,"given":"Kazushige","family":"Tsunoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,9]]},"reference":[{"issue":"5","key":"9782_CR1","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/s1474-4422(04)00737-9","volume":"3","author":"L Sch\u00f6ls","year":"2004","unstructured":"Sch\u00f6ls L, Bauer P, Schmidt T, Schulte T, Riess O (2004) Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis. Lancet Neurol 3(5):291\u2013304. https:\/\/doi.org\/10.1016\/s1474-4422(04)00737-9","journal-title":"Lancet Neurol"},{"issue":"10","key":"9782_CR2","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1001\/archopht.118.10.1415","volume":"118","author":"T Abe","year":"2000","unstructured":"Abe T, Tsuda T, Yoshida M, Wada Y, Kano T, Itoyama Y, Tamai M (2000) Macular degeneration associated with aberrant expansion of trinucleotide repeat of the SCA7 gene in 2 Japanese families. Arch Ophthalmol 118(10):1415\u20131421. https:\/\/doi.org\/10.1001\/archopht.118.10.1415","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"9782_CR3","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s10633-015-9488-8","volume":"130","author":"S Katagiri","year":"2015","unstructured":"Katagiri S, Hayashi T, Takeuchi T, Yamada H, Gekka T, Kawabe K, Kurita A, Tsuneoka H (2015) Somatic instability of expanded CAG repeats of ATXN7 in Japanese patients with spinocerebellar ataxia type 7. Doc Ophthalmol 130(3):189\u2013195. https:\/\/doi.org\/10.1007\/s10633-015-9488-8","journal-title":"Doc Ophthalmol"},{"issue":"1","key":"9782_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/13816810802454081","volume":"30","author":"T Hugosson","year":"2009","unstructured":"Hugosson T, Gr\u00e4nse L, Ponjavic V, Andr\u00e9asson S (2009) Macular dysfunction and morphology in spinocerebellar ataxia type 7 (SCA 7). Ophthalmic Genet 30(1):1\u20136. https:\/\/doi.org\/10.1080\/13816810802454081","journal-title":"Ophthalmic Genet"},{"issue":"3","key":"9782_CR5","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/icb.0000000000000248","volume":"10","author":"JD Levinson","year":"2016","unstructured":"Levinson JD, Yan J, Lambert SR, Shankar SP (2016) Multimodal imaging of a family with spinocerebellar ataxia type 7 demonstrating phenotypic variation and progression of retinal degeneration. Retinal Cases Brief Rep 10(3):267\u2013272. https:\/\/doi.org\/10.1097\/icb.0000000000000248","journal-title":"Retinal Cases Brief Rep"},{"issue":"3","key":"9782_CR6","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1080\/13816810.2019.1633548","volume":"40","author":"JY Park","year":"2019","unstructured":"Park JY, Wy SY, Joo K, Woo SJ (2019) Spinocerebellar ataxia type 7 with RP1L1-negative occult macular dystrophy as retinal manifestation. Ophthalmic Genet 40(3):282\u2013285. https:\/\/doi.org\/10.1080\/13816810.2019.1633548","journal-title":"Ophthalmic Genet"},{"issue":"3","key":"9782_CR7","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/ng0793-221","volume":"4","author":"HT Orr","year":"1993","unstructured":"Orr HT, Chung MY, Banfi S, Kwiatkowski TJ Jr, Servadio A, Beaudet AL, McCall AE, Duvick LA, Ranum LP, Zoghbi HY (1993) Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nat Genet 4(3):221\u2013226. https:\/\/doi.org\/10.1038\/ng0793-221","journal-title":"Nat Genet"},{"key":"9782_CR8","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1750-1172-6-33","volume":"6","author":"NR Whaley","year":"2011","unstructured":"Whaley NR, Fujioka S, Wszolek ZK (2011) Autosomal dominant cerebellar ataxia type I: a review of the phenotypic and genotypic characteristics. Orphanet J Rare Dis 6:33. https:\/\/doi.org\/10.1186\/1750-1172-6-33","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"9782_CR9","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1001\/archopht.1997.01100150233013","volume":"115","author":"T Abe","year":"1997","unstructured":"Abe T, Abe K, Aoki M, Itoyama Y, Tamai M (1997) Ocular changes in patients with spinocerebellar degeneration and repeated trinucleotide expansion of spinocerebellar ataxia type 1 gene. Arch Ophthalmol 115(2):231\u2013236. https:\/\/doi.org\/10.1001\/archopht.1997.01100150233013","journal-title":"Arch Ophthalmol"},{"issue":"1\u20132","key":"9782_CR10","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/0022-510x(96)00140-2","volume":"142","author":"A Perretti","year":"1996","unstructured":"Perretti A, Santoro L, Lanzillo B, Filla A, De Michele G, Barbieri F, Martino G, Ragno M, Cocozza S, Caruso G (1996) Autosomal dominant cerebellar ataxia type I: multimodal electrophysiological study and comparison between SCA1 and SCA2 patients. J Neurol Sci 142(1\u20132):45\u201353. https:\/\/doi.org\/10.1016\/0022-510x(96)00140-2","journal-title":"J Neurol Sci"},{"issue":"12","key":"9782_CR11","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1093\/brain\/120.12.2141","volume":"120","author":"M Abele","year":"1997","unstructured":"Abele M, B\u00fcrk K, Andres F, Topka H, Laccone F, B\u00f6sch S, Brice A, Cancel G, Dichgans J, Klockgether T (1997) Autosomal dominant cerebellar ataxia type I. Nerve conduction and evoked potential studies in families with SCA1, SCA2 and SCA3. Brain: J Neurol 120(12):2141\u20132148. https:\/\/doi.org\/10.1093\/brain\/120.12.2141","journal-title":"Brain: J Neurol"},{"issue":"11","key":"9782_CR12","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1136\/jnnp.2006.092676","volume":"77","author":"Y Saito","year":"2006","unstructured":"Saito Y, Matsumura K, Shimizu S, Ichikawa Y, Ochiai K, Goto J, Tsuji S, Shimizu T (2006) Pigmentary macular dystrophy in spinocerebellar ataxia type 1. J Neurol Neurosurg Psychiatry 77(11):1293. https:\/\/doi.org\/10.1136\/jnnp.2006.092676","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"9782_CR13","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3109\/01658107.2011.580898","volume":"35","author":"JH Pula","year":"2011","unstructured":"Pula JH, Towle VL, Staszak VM, Cao D, Bernard JT, Gomez CM (2011) Retinal nerve fibre layer and macular thinning in spinocerebellar ataxia and cerebellar multisystem atrophy. Neuro-ophthalmology 35(3):108\u2013114. https:\/\/doi.org\/10.3109\/01658107.2011.580898","journal-title":"Neuro-ophthalmology"},{"issue":"7","key":"9782_CR14","doi-asserted-by":"publisher","first-page":"e23024","DOI":"10.1371\/journal.pone.0023024","volume":"6","author":"S Stricker","year":"2011","unstructured":"Stricker S, Oberwahrenbrock T, Zimmermann H, Schroeter J, Endres M, Brandt AU, Paul F (2011) Temporal retinal nerve fiber loss in patients with spinocerebellar ataxia type 1. PLoS ONE 6(7):e23024. https:\/\/doi.org\/10.1371\/journal.pone.0023024","journal-title":"PLoS ONE"},{"issue":"7","key":"9782_CR15","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1001\/archophthalmol.2011.172","volume":"129","author":"MJ Thurtell","year":"2011","unstructured":"Thurtell MJ, Biousse V, Newman NJ (2011) Rod-cone dystrophy in spinocerebellar ataxia type 1. Arch Ophthalmol 129(7):956\u2013958. https:\/\/doi.org\/10.1001\/archophthalmol.2011.172","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"9782_CR16","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1097\/WNO.0b013e31828d4add","volume":"33","author":"P Lebranchu","year":"2013","unstructured":"Lebranchu P, Le Meur G, Magot A, David A, Verny C, Weber M, Milea D (2013) Maculopathy and spinocerebellar ataxia type 1: a new association? J Neuro-ophthalmol 33(3):225\u2013231. https:\/\/doi.org\/10.1097\/WNO.0b013e31828d4add","journal-title":"J Neuro-ophthalmol"},{"issue":"4","key":"9782_CR17","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1001\/jamaophthalmol.2013.1127","volume":"131","author":"V Vaclavik","year":"2013","unstructured":"Vaclavik V, Borruat FX, Ambresin A, Munier FL (2013) Novel maculopathy in patients with spinocerebellar ataxia type 1 autofluorescence findings and functional characteristics. JAMA Ophthalmol 131(4):536\u2013538. https:\/\/doi.org\/10.1001\/jamaophthalmol.2013.1127","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"9782_CR18","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1080\/13816810.2019.1571614","volume":"40","author":"KM Nishiguchi","year":"2019","unstructured":"Nishiguchi KM, Aoki M, Nakazawa T, Abe T (2019) Macular degeneration as a common cause of visual loss in spinocerebellar ataxia type 1 (SCA1) patients. Ophthalmic Genet 40(1):49\u201353. https:\/\/doi.org\/10.1080\/13816810.2019.1571614","journal-title":"Ophthalmic Genet"},{"issue":"2","key":"9782_CR19","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s12311-008-0024-1","volume":"7","author":"L Sch\u00f6ls","year":"2008","unstructured":"Sch\u00f6ls L, Linnemann C, Globas C (2008) Electrophysiology in spinocerebellar ataxias: spread of disease and characteristic findings. Cerebellum 7(2):198\u2013203. https:\/\/doi.org\/10.1007\/s12311-008-0024-1","journal-title":"Cerebellum"},{"key":"9782_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajo.2017.10.032","volume":"186","author":"CX Cai","year":"2018","unstructured":"Cai CX, Light JG, Handa JT (2018) Quantifying the rate of ellipsoid zone loss in stargardt disease. Am J Ophthalmol 186:1\u20139. https:\/\/doi.org\/10.1016\/j.ajo.2017.10.032","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"9782_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1167\/tvst.8.2.1","volume":"8","author":"P Tanna","year":"2019","unstructured":"Tanna P, Georgiou M, Strauss RW, Ali N, Kumaran N, Kalitzeos A, Fujinami K, Michaelides M (2019) Cross-sectional and longitudinal assessment of the ellipsoid zone in childhood-onset stargardt disease. Transl Vis Sci Technol 8(2):1. https:\/\/doi.org\/10.1167\/tvst.8.2.1","journal-title":"Transl Vis Sci Technol"},{"issue":"1","key":"9782_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10633-014-9473-7","volume":"130","author":"DL McCulloch","year":"2015","unstructured":"McCulloch DL, Marmor MF, Brigell MG, Hamilton R, Holder GE, Tzekov R, Bach M (2015) ISCEV Standard for full-field clinical electroretinography (2015 update). Doc Ophthalmol 130(1):1\u201312. https:\/\/doi.org\/10.1007\/s10633-014-9473-7","journal-title":"Doc Ophthalmol"},{"issue":"1","key":"9782_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10633-011-9296-8","volume":"124","author":"DC Hood","year":"2012","unstructured":"Hood DC, Bach M, Brigell M, Keating D, Kondo M, Lyons JS, Marmor MF, McCulloch DL, Palmowski-Wolfe AM (2012) ISCEV standard for clinical multifocal electroretinography (mfERG) (2011 edition). Doc Ophthalmol 124(1):1\u201313. https:\/\/doi.org\/10.1007\/s10633-011-9296-8","journal-title":"Doc Ophthalmol"},{"issue":"14","key":"9782_CR24","doi-asserted-by":"publisher","first-page":"4691","DOI":"10.1167\/iovs.19-27486","volume":"60","author":"N Nakamura","year":"2019","unstructured":"Nakamura N, Tsunoda K, Mizuno Y, Usui T, Hatase T, Ueno S, Kuniyoshi K, Hayashi T, Katagiri S, Kondo M, Kameya S, Yoshitake K, Fujinami K, Iwata T, Miyake Y (2019) Clinical stages of occult macular dystrophy based on optical coherence tomographic findings. Invest Ophthalmol Vis Sci 60(14):4691\u20134700. https:\/\/doi.org\/10.1167\/iovs.19-27486","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"9782_CR25","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/0002-9394(89)90120-7","volume":"108","author":"Y Miyake","year":"1989","unstructured":"Miyake Y, Ichikawa K, Shiose Y, Kawase Y (1989) Hereditary macular dystrophy without visible fundus abnormality. Am J Ophthalmol 108(3):292\u2013299","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"9782_CR26","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s10384-015-0371-7","volume":"59","author":"Y Miyake","year":"2015","unstructured":"Miyake Y, Tsunoda K (2015) Occult macular dystrophy. Jpn J Ophthalmol 59(2):71\u201380. https:\/\/doi.org\/10.1007\/s10384-015-0371-7","journal-title":"Jpn J Ophthalmol"},{"issue":"11","key":"9782_CR27","doi-asserted-by":"publisher","first-page":"4837","DOI":"10.1167\/iovs.16-19670","volume":"57","author":"K Fujinami","year":"2016","unstructured":"Fujinami K, Kameya S, Kikuchi S, Ueno S, Kondo M, Hayashi T, Shinoda K, Machida S, Kuniyoshi K, Kawamura Y, Akahori M, Yoshitake K, Katagiri S, Nakanishi A, Sakuramoto H, Ozawa Y, Tsubota K, Yamaki K, Mizota A, Terasaki H, Miyake Y, Iwata T, Tsunoda K (2016) Novel RP1L1 variants and genotype-photoreceptor microstructural phenotype associations in Cohort of Japanese patients with occult macular dystrophy. Invest Ophthalmol Vis Sci 57(11):4837\u20134846. https:\/\/doi.org\/10.1167\/iovs.16-19670","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"9782_CR28","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.ajhg.2010.08.009","volume":"87","author":"M Akahori","year":"2010","unstructured":"Akahori M, Tsunoda K, Miyake Y, Fukuda Y, Ishiura H, Tsuji S, Usui T, Hatase T, Nakamura M, Ohde H, Itabashi T, Okamoto H, Takada Y, Iwata T (2010) Dominant mutations in RP1L1 are responsible for occult macular dystrophy. Am J Hum Genet 87(3):424\u2013429","journal-title":"Am J Hum Genet"},{"issue":"6","key":"9782_CR29","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1097\/Iae.0b013e318232c32e","volume":"32","author":"K Tsunoda","year":"2012","unstructured":"Tsunoda K, Usui T, Hatase T, Yamai S, Fujinami K, Hanazono G, Shinoda K, Ohde H, Akahori M, Iwata T, Miyake Y (2012) Clinical characteristics of occult macular dystrophy in family with mutation of Rp1l1 GENE. Retina J Retinal Vitreous Dis 32(6):1135\u20131147. https:\/\/doi.org\/10.1097\/Iae.0b013e318232c32e","journal-title":"Retina J Retinal Vitreous Dis"},{"issue":"5","key":"9782_CR30","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1001\/archophthalmol.2011.96","volume":"129","author":"K Fujinami","year":"2011","unstructured":"Fujinami K, Tsunoda K, Hanazono G, Shinoda K, Ohde H, Miyake Y (2011) Fundus autofluorescence in autosomal dominant occult macular dystrophy. Arch Ophthalmol 129(5):597\u2013602","journal-title":"Arch Ophthalmol"},{"issue":"9","key":"9782_CR31","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1001\/jamaophthalmol.2013.4160","volume":"131","author":"DG Birch","year":"2013","unstructured":"Birch DG, Locke KG, Wen Y, Locke KI, Hoffman DR, Hood DC (2013) Spectral-domain optical coherence tomography measures of outer segment layer progression in patients with X-linked retinitis pigmentosa. JAMA Ophthalmol 131(9):1143\u20131150. https:\/\/doi.org\/10.1001\/jamaophthalmol.2013.4160","journal-title":"JAMA Ophthalmol"},{"issue":"4","key":"9782_CR32","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.ajo.2015.06.032","volume":"160","author":"T Sujirakul","year":"2015","unstructured":"Sujirakul T, Lin MK, Duong J, Wei Y, Lopez-Pintado S, Tsang SH (2015) Multimodal imaging of central retinal disease progression in a 2-year mean follow-up of retinitis pigmentosa. Am J Ophthalmol 160(4):786\u2013798. https:\/\/doi.org\/10.1016\/j.ajo.2015.06.032","journal-title":"Am J Ophthalmol"},{"key":"9782_CR33","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ajo.2018.10.003","volume":"198","author":"JJL Tee","year":"2019","unstructured":"Tee JJL, Yang Y, Kalitzeos A, Webster A, Bainbridge J, Michaelides M (2019) Natural history study of retinal structure, progression, and symmetry using ellipzoid zone metrics in RPGR-associated retinopathy. Am J Ophthalmol 198:111\u2013123. https:\/\/doi.org\/10.1016\/j.ajo.2018.10.003","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"9782_CR34","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/ng0595-94","volume":"10","author":"A Servadio","year":"1995","unstructured":"Servadio A, Koshy B, Armstrong D, Antalffy B, Orr HT, Zoghbi HY (1995) Expression analysis of the ataxin-1 protein in tissues from normal and spinocerebellar ataxia type 1 individuals. Nat Genet 10(1):94\u201398. https:\/\/doi.org\/10.1038\/ng0595-94","journal-title":"Nat Genet"},{"issue":"5222","key":"9782_CR35","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1126\/science.7618107","volume":"269","author":"MP Duyao","year":"1995","unstructured":"Duyao MP, Auerbach AB, Ryan A, Persichetti F, Barnes GT, McNeil SM, Ge P, Vonsattel JP, Gusella JF, Joyner AL et al (1995) Inactivation of the mouse Huntington\u2019s disease gene homolog Hdh. Science 269(5222):407\u2013410. https:\/\/doi.org\/10.1126\/science.7618107","journal-title":"Science"},{"issue":"7","key":"9782_CR36","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1016\/j.cell.2006.11.038","volume":"127","author":"YC Lam","year":"2006","unstructured":"Lam YC, Bowman AB, Jafar-Nejad P, Lim J, Richman R, Fryer JD, Hyun ED, Duvick LA, Orr HT, Botas J, Zoghbi HY (2006) ATAXIN-1 interacts with the repressor Capicua in its native complex to cause SCA1 neuropathology. Cell 127(7):1335\u20131347. https:\/\/doi.org\/10.1016\/j.cell.2006.11.038","journal-title":"Cell"},{"issue":"2","key":"9782_CR37","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s13311-018-00696-y","volume":"16","author":"RAM Buijsen","year":"2019","unstructured":"Buijsen RAM, Toonen LJA, Gardiner SL, van Roon-Mom WMC (2019) Genetics, mechanisms, and therapeutic progress in polyglutamine spinocerebellar ataxias. Neurotherapeutics 16(2):263\u2013286. https:\/\/doi.org\/10.1007\/s13311-018-00696-y","journal-title":"Neurotherapeutics"},{"key":"9782_CR38","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.omtn.2019.07.004","volume":"17","author":"E Kourkouta","year":"2019","unstructured":"Kourkouta E, Weij R, Gonz\u00e1lez-Barriga A, Mulder M, Verheul R, Bosgra S, Groenendaal B, Puoliv\u00e4li J, Toivanen J, van Deutekom JCT, Datson NA (2019) Suppression of mutant protein expression in SCA3 and SCA1 mice using a CAG repeat-targeting antisense oligonucleotide. Mol Ther Nucleic Acids 17:601\u2013614. https:\/\/doi.org\/10.1016\/j.omtn.2019.07.004","journal-title":"Mol Ther Nucleic Acids"},{"key":"9782_CR39","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.123193","author":"J Friedrich","year":"2018","unstructured":"Friedrich J, Kordasiewicz HB, O\u2019Callaghan B, Handler HP, Wagener C, Duvick L, Swayze EE, Rainwater O, Hofstra B, Benneyworth M, Nichols-Meade T, Yang P, Chen Z, Ortiz JP, Clark HB, \u00d6z G, Larson S, Zoghbi HY, Henzler C, Orr HT (2018) Antisense oligonucleotide-mediated ataxin-1 reduction prolongs survival in SCA1 mice and reveals disease-associated transcriptome profiles. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.123193","journal-title":"JCI Insight"},{"issue":"2","key":"9782_CR40","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41591-018-0295-0","volume":"25","author":"AV Cideciyan","year":"2019","unstructured":"Cideciyan AV, Jacobson SG, Drack AV, Ho AC, Charng J, Garafalo AV, Roman AJ, Sumaroka A, Han IC, Hochstedler MD, Pfeifer WL, Sohn EH, Taiel M, Schwartz MR, Biasutto P, Wit W, Cheetham ME, Adamson P, Rodman DM, Platenburg G, Tome MD, Balikova I, Nerinckx F, Zaeytijd J, Van Cauwenbergh C, Leroy BP, Russell SR (2019) Effect of an intravitreal antisense oligonucleotide on vision in Leber congenital amaurosis due to a photoreceptor cilium defect. Nat Med 25(2):225\u2013228. https:\/\/doi.org\/10.1038\/s41591-018-0295-0","journal-title":"Nat Med"}],"container-title":["Documenta Ophthalmologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10633-020-09782-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10633-020-09782-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10633-020-09782-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T23:40:40Z","timestamp":1625787640000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10633-020-09782-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,9]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["9782"],"URL":"https:\/\/doi.org\/10.1007\/s10633-020-09782-z","relation":{},"ISSN":["0012-4486","1573-2622"],"issn-type":[{"value":"0012-4486","type":"print"},{"value":"1573-2622","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,9]]},"assertion":[{"value":"21 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Author KT has received financial research support from Astellas and speaker honorarium from Novartis, Santen, and Senju. Other authors have no financial disclosure.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent was obtained from the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee (Review Board\/Ethics Committee of the National Institute of Sensory Organs, National Hospital Organization, Tokyo Medical Center, Reference: R18-029) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of human rights"}},{"value":"This article does not contain any studies with animals performed by any of the authors.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement on the welfare of animals"}}]}}